| Year |
Citation |
Score |
| 2023 |
Zhu R, Wang X, Anderson E, Deng M, Pivirotto S, Jin J, Kassir N, Owen R. Population-Based Pharmacodynamic Modeling of Omalizumab in Pediatric Patients with Moderate to Severe Persistent Inadequately Controlled Allergic Asthma. The Aaps Journal. 25: 56. PMID 37266853 DOI: 10.1208/s12248-023-00823-4 |
0.362 |
|
| 2017 |
Zhu R, Zheng Y, Dirks NL, Vadhavkar S, Jin JY, Peng K, Holweg CTJ, Olsson J, Matthews JG, Putnam WS. Model-based clinical pharmacology profiling and exposure-response relationships of the efficacy and biomarker of lebrikizumab in patients with moderate-to-severe asthma. Pulmonary Pharmacology & Therapeutics. PMID 28843617 DOI: 10.1016/J.Pupt.2017.08.010 |
0.319 |
|
| 2013 |
Zhu R, Zheng Y, Putnam WS, Visich J, Eisner MD, Matthews JG, Rosen KE, D'Argenio DZ. Population-based efficacy modeling of omalizumab in patients with severe allergic asthma inadequately controlled with standard therapy. The Aaps Journal. 15: 559-70. PMID 23413101 DOI: 10.1208/S12248-013-9463-9 |
0.554 |
|
| 2012 |
Kiser JJ, Zhu R, DʼArgenio DZ, Cotton MF, Bobat R, McSherry GD, Madhi SA, Carey VJ, Seifart HI, Werely CJ, Fletcher CV. Isoniazid pharmacokinetics, pharmacodynamics, and dosing in South African infants. Therapeutic Drug Monitoring. 34: 446-51. PMID 22695364 DOI: 10.1097/Ftd.0B013E31825C4Bc3 |
0.545 |
|
| 2012 |
Zhu R, Kiser JJ, Seifart HI, Werely CJ, Mitchell CD, D'Argenio DZ, Fletcher CV. The pharmacogenetics of NAT2 enzyme maturation in perinatally HIV exposed infants receiving isoniazid. Journal of Clinical Pharmacology. 52: 511-9. PMID 21558457 DOI: 10.1177/0091270011402826 |
0.544 |
|
| Show low-probability matches. |